Cargando…
Can we improve outcomes in AF patients by early therapy?
Atrial fibrillation affects at least 1% of the population and causes marked society-wide morbidity and mortality. Current management of atrial fibrillation including antithrombotic therapy and management of concomitant conditions in all patients, rate control therapy in most patients, and rhythm con...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788576/ https://www.ncbi.nlm.nih.gov/pubmed/19941634 http://dx.doi.org/10.1186/1741-7015-7-72 |